Removal of leukoplakia and other oral mucosal lesions using laser ablation - a two-part study with different patient groups and laser methods

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035429

Enrollment

Registered

2024-11-11

Start date

2024-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leuplacia, Lichen ruber mucosae K13.2

Interventions

Group 1: Healing of leukoplakia after treatment with carbondioxid laser in immunosuppressed and non-immunosuppressed patients. Observation period 1 year. Group 2: Comparison of two different treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: immunocomprommised and non-immunocompromised patients

Exclusion criteria

Exclusion criteria: multimorbid patients

Design outcomes

Primary

Measure	Time frame
Healing processes are assessed on the basis of clinical progress checks with assessment of signs of inflammation.	—

Secondary

Measure	Time frame
Postoperative pain is evaluated using questionnaires	—

Countries

Germany

Contacts

Public ContactOlivia Höfer

Klinik für Mund-, Kiefer- und Gesichtschirurgie

olivia.hoefer@uniklinik-freiburg.de0761-27047020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026